MedTrace Logo

Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases

NCT00815984 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2010-02-10

No results posted yet for this study

Summary

In about 800 children with allergic diseases (asthma, allergic rhinitis, atopic dermatitis) the investigators will retrospectively and cross-sectionally analyze the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Conditions

Interventions

PROCEDURE

measurements of lung function tests

Measurement of the concentration of FeNO , measurement of spirometry, plethysmography, exercise challenge test (ECT -spirometric), bronchial obstruction reversibility pharmacological test

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Iwona Stelmach, MD PhD Prof · Department of Pediatrics and Allergy, N. Copernicus Hospital, Lodz, Poland

  • Tomasz Grzelewski, MD, PhD · Department of Pediatrics and Allergy, N. Copernicus Hospital, Lodz, Poland

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00815984 on ClinicalTrials.gov